Tomonori Oura

16PUBLICATIONS
20CO-AUTHORS
Pacific Peoples life coursePharmacogenomicsFood properties (incl. characteristics and health benefits)Nutrigenomics and personalised nutritionPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 10, 2026
Effect of Tirzepatide on Health-Related Quality of Life in Japanese Patients With Obesity Disease: Patient-Reported Outcomes From the SURMOUNT-J Study.

|Nov 25, 2025
Association of baseline characteristics with clinical outcomes of tirzepatide treatment in Japanese patients with obesity disease: A subgroup analysis of the SURMOUNT-J trial.

Koutaro Yokote, Yasushi Fukushima, Tomotaka Shingaki

|Jul 25, 2025
Association Between Early Weight Loss and Metabolic Outcomes with Tirzepatide in Japanese Patients with Type 2 Diabetes: A SURPASS J Post Hoc Analysis.

Hanaka Mimura, Tomonori Oura, Rina Chin

|Jun 09, 2025
Efficacy and safety of once-weekly tirzepatide in Japanese participants with type 2 diabetes who have obesity or overweight: Subpopulation analysis of the SURMOUNT-2 trial.

Toshimasa Yamauchi, Taro Asakura, Tomotaka Shingaki

|Feb 14, 2025
Insulin Sensitivity and Beta-Cell Function Following Tirzepatide in Japanese Patients with Type 2 Diabetes: A SURPASS J-mono Analysis.

Yoshiyuki Hamamoto, Tomonori Oura, Tetsuaki Hirase

|Feb 10, 2025
Pharmacokinetic and Pharmacodynamic Properties of Once-Weekly Insulin Efsitora Alfa in Japanese Patients with Type 2 Diabetes.

Risa Nasu, Tomonori Oura, Kenji Ohwaki

Pageof 3

Frequent Collaborators

7 joint publications

Masakazu Takeuchi

3 joint publications

Tetsuaki Hirase

3 joint publications

Tomotaka Shingaki

2 joint publications

Rina Chin